HRTX

HRTX Operating Income Growth

-981.82%TTM

Period ending:

HRTX TTM Operating Income YoY %%
HRTX TTM Operating Income YoY %2433.04%-7725.04%
1988-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

HRTX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 151 observations from Dec 31, 1988 to Jun 30, 2026.

Heron Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-981.8182%
-192.4217%
77.984%
106.161%
102.6556%
95.6576%
89.5783%
78.5333%
66.3101%
43.1277%
36.6677%
41.9024%
36.7366%
36.669%
19.8184%
7.867%
6.2847%
-0.4808%
4.5297%
0.2838%
-14.5857%
-14.4997%
-8.2912%
-11.6375%
3.2805%
-1.0582%
-14.5468%
-4.1812%
-8.0012%
0.3052%
5.459%
-8.3813%
-4.3875%
-5.5361%
-13.8332%
-15.6594%
-43.0712%
-70.1011%
-76.3374%
-81.7854%
-58.7947%
-41.5959%
-29.9942%
-23.8933%
-30.6873%
-31.4636%
-36.9172%
-39.8859%
-46.8213%
-85.5378%
-128.5133%
-154.9195%
-145.696%
-119.1651%
-115.4312%
-122.6691%
-178.9009%
-73.2633%
-11.3549%
15.7655%
37.0078%
17.4093%
3.0072%
13.9648%
42.0144%
47.5111%
56.3129%
56.3491%
35.4366%
21.4837%
0.9841%
-27.0626%
-29.9966%
-19.4101%
-25.5142%
-36.5143%
-48.1463%
-78.2515%
-122.6103%
-94.3345%
-65.924%
-43.6879%
9.0382%
4.2255%
-6.2395%
-10.0055%
-40.9167%
-51.8499%
-33.9249%
-33.309%
-34.3972%
11.9175%
15.1462%
18.0161%
26.6149%
2.6066%
-24.772%
-34.5798%
-100.13%
-6,742.0004%

Compare operating income growth

All HRTX financial metrics · HRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.